Recommended Topic Related To:

A-Methapred

"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...

A-Methapred

A-Methapred Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

A-Methapred (methylprednisolone sodium succinate) is an anti-inflammatory steroid used to treat conditions such as arthritis, lupus, dermatitis, Steven's-Johnson Syndrome, asthma, eye inflammation, ulcerative colitis, leukemia, multiple sclerosis, and more. It is available in generic form. Common side effects of A-Methapred include muscle weakness, peptic ulcer, slow wound healing, vertigo, headache, changes in menstrual cycle, and increased eye pressure.

Dosage recommendations for A-Methapred vary for each individual. Talk to your doctor about your individual dosage recommendation. Cyclosporin can interact with A-Methapred. Tell your doctor all medications you are taking. Do not take A-Methapred while getting vaccinated for smallpox. Prolonged use of A-Methapred may cause optic nerve damage, eye infections, or glaucoma. Caution should be exercised if you take A-Methapred while pregnant or breastfeeding.

Our A-Methapred (methylprednisolone sodium succinate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

A-Methapred FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Fluid and Electrolyte Disturbances

Sodium retention, Fluid retention, Congestive heart failure in susceptible patients, Potassium loss, Hypokalemic alkalosis, Hypertension

Musculoskeletal

Muscle weakness, Steroid myopathy, Loss of muscle mass, Severe arthralgia, Vertebral compression fractures, Aseptic necrosis of femoral and humeral heads, Pathologic fracture of long bones, Osteoporosis

Gastrointestinal

Peptic ulcer with possible perforation and hemorrhage, Pancreatitis, Abdominal distention, and Ulcerative esophagitis

Dermatologic

Impaired wound healing, Thin fragile skin, Petechiae and ecchymoses, Facial erythema, Increased sweating, May suppress reactions to skin tests

Neurological

Increased intracranial pressure with papilledema (pseudo-tumor cerebri) usually after treatment, Convulsions, Vertigo, Headache

Endocrine

Development of Cushingoid state, Suppression of growth in children, Secondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery or illness, Menstrual irregularities, Decreased carbohydrate tolerance, Manifestations of latent diabetes mellitus, Increased requirements for insulin or oral hypoglycemic agents in diabetics

Ophthalmic

Posterior subcapsular cataracts, Increased intraocular pressure, Glaucoma, Exophthalmos

Metabolic

Negative nitrogen balance due to protein catabolism

The following additional adverse reactions are related to parenteral corticosteroid therapy: Hyperpigmentation or hypopigmentation, Subcutaneous and cutaneous atrophy, Sterile abscess, Anaphylactic reaction with or without circulatory collapse, cardiac arrest, bronchospasm, Urticaria, Nausea and vomiting, Cardiac arrhythmias; hypotension or hypertension

Read the entire FDA prescribing information for A-Methapred (Methylprednisolone Sodium Succinate) »

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.